Mariusz Gasior to Acute Coronary Syndrome
This is a "connection" page, showing publications Mariusz Gasior has written about Acute Coronary Syndrome.
Connection Strength
0.900
-
Characteristics of patients from the Polish Registry of Acute Coronary Syndromes during the COVID-19 pandemic: the first report. Kardiol Pol. 2021 02 25; 79(2):192-195.
Score: 0.327
-
Comparison of multivessel percutaneous coronary intervention and coronary artery bypass grafting in patients with severe coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes. Kardiol Pol. 2018; 76(10):1474-1481.
Score: 0.279
-
Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stent. Medicine (Baltimore). 2019 Apr; 98(14):e15106.
Score: 0.072
-
Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes - Data from the TERCET registry with 19,287 patients. Pharmacol Res. 2019 01; 139:460-466.
Score: 0.071
-
Risk factors predisposing to acute coronary syndromes in young women =45 years of age. Int J Cardiol. 2018 08 01; 264:165-169.
Score: 0.067
-
Evaluation of dyslipidaemia and the impact of hypolipidemic therapy on prognosis in high and very high risk patients through the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) Registry. Pharmacol Res. 2018 06; 132:204-210.
Score: 0.066
-
Impact of routine invasive strategy on outcomes in patients with non-ST-segment elevation myocardial infarction during 2005-2014: A report from the Polish Registry of Acute Coronary Syndromes (PL-ACS). Cardiol J. 2020; 27(5):583-589.
Score: 0.018